On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir. [electronic resource]
Producer: 20171020Description: 1611-1618 p. digitalISSN:- 1478-3231
- Adult
- Aged
- Antiviral Agents -- administration & dosage
- Carbamates
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Imidazoles -- administration & dosage
- Liver Cirrhosis -- blood
- Male
- Middle Aged
- Pyrrolidines
- RNA, Viral -- blood
- Sofosbuvir -- administration & dosage
- Sustained Virologic Response
- Time Factors
- United States
- Valine -- analogs & derivatives
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article
There are no comments on this title.
Log in to your account to post a comment.